Tellgen Corporation
300642
Clasificación en acciones
#13492
Tellgen Corporation is dedicated to the creation, manufacturing, and supply of... Tellgen Corporation is dedicated to the creation, manufacturing, and supply of in-vitro diagnostic (IVD) solutions, serving both the Chinese domestic market and a global clientele. Their extensive product catalog includes cancer detection markers, test kits for human papilloma virus (HPV), ToRCH diagnostic assays, Y-chromosome microdeletion screening kits, and sophisticated multiplex immunoassay systems. The company, founded in 2003, operates from its headquarters in Shanghai, China.
Precio por acción
$2.87
Capitalización bursátil
$465.09M
Cambio (1 día)
7.08%
Cambio (1 año)
-23.69%
País
CN
Comercio Tellgen Corporation (300642)
Categoría
Healthcare
Ganancias de Tellgen Corporation (300642)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Tellgen Corporation, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Tellgen Corporation desde 2026 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| Not enough data for the provided dates. | ||
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| $7.51B | - |
US
|
|
| $5.56B | - |
IE
|
|
| $5.15B | - |
US
|
|
| $3.86B | - |
US
|
|
| - | - |
DE
|
